Jove
Visualize
Contact Us

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

655
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
655
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

319
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
319
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

193
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
193
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe Hypertriglyceridemia-Induced Pancreatitis in Pregnancy: A Dreaded Combination.

Journal of obstetrics and gynaecology of India·2023
Same author

Fatal Disseminated Strongyloidiasis in Steroid Overuse.

JCEM case reports·2023
Same author

The role of body mass index or metabolic syndrome components causing depression in women: An observation from weight reduction clinical trial.

Journal of clinical pharmacy and therapeutics·2021
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 28, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

440

Drug-Induced Atypical Lipodystrophy.

Priyadarshini Rajakumar1, Shriraam Mahadevan1, Adlyne Reena Asirvatham1

  • 1Department of Endocrinology, Sri Ramachandra Medical College and Research Institute, Chennai 600116, Tamilnadu, India.

JCEM Case Reports
|April 19, 2024
PubMed
Summary
This summary is machine-generated.

This case study details a patient with abnormal fat accumulation due to prolonged corticosteroid and anabolic steroid use. The combined steroids presented atypical symptoms, highlighting the need for medical awareness.

Keywords:
anabolic steroidsatypical lipodystrophydrug-induced lipodystrophysteroid abusesteroid effects

More Related Videos

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle
11:50

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle

Published on: June 8, 2022

4.1K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K

Related Experiment Videos

Last Updated: Jun 28, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

440
Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle
11:50

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle

Published on: June 8, 2022

4.1K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Prolonged use of corticosteroids and anabolic steroids can lead to significant adverse health effects.
  • Anabolic-androgenic steroids are sometimes used concurrently with glucocorticoids for performance or appearance enhancement.

Observation:

  • A patient presented with unusual fat deposition in the torso and upper arms after 7 years of combined steroid use.
  • Despite extensive steroid exposure, the patient showed no signs of Cushingoid phenotype or metabolic disturbances.
  • Bone density, cardiac function, and liver health remained normal, with no evidence of excess fat accumulation in these organs.

Findings:

  • The concurrent use of anabolic steroids appeared to mitigate typical corticosteroid-induced side effects, such as muscle and bone loss.
  • This protective effect mirrors observations in pediatric Cushing syndrome, where androgens and activity preserve muscle and bone mass.
  • The patient was withdrawn from the drugs and managed with hydrocortisone replacement therapy, with surgical correction planned.

Implications:

  • Medical providers must recognize the continued use of combined anabolic and glucocorticoid steroids for non-medical purposes like weight-building.
  • Patients using these drug combinations may exhibit atypical clinical presentations, necessitating careful diagnostic evaluation.
  • Awareness of these atypical presentations is crucial for appropriate patient management and treatment strategies.